Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Potential of Senolytics in Cardiovascular Disease

26 Sept 2020

Abstract excerpt

Ageing is the biggest risk factor for impaired cardiovascular health, with cardiovascular disease being the leading cause of death in 40% of individuals over 65 years old. Ageing is associated with both an increased prevalence of cardiovascular disease including heart failure, coronary artery disease, and myocardial infarction. Furthermore, ageing is associated with a poorer prognosis to these diseases. Genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32979174
DOI: 10.1007/s10557-020-07075-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Potential of Senolytics in Cardiovascular DiseasePMID 32979174Read ↗

Therapeutic opportunities for senolysis in cardiovascular diseaseSemantic proximity Read ↗

Cellular senescence and cardiovascular diseases: moving to the “heart” of the problemSemantic proximity Read ↗

From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugsSemantic proximity Read ↗

Cellular senescence in cardiac diseasesSemantic proximity Read ↗

Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and ModelsSemantic proximity Read ↗

Current senolytics: Mode of action, efficacy and limitations, and their future.Semantic proximity Read ↗

Recent Advances in Senolysis for Age-Related DiseasesSemantic proximity Read ↗

Senolytics: Targeting Senescent Cells for Age-Associated DiseasesSemantic proximity Read ↗

Discovery, development, and future application of senolytics: theories and predictions.Semantic proximity Read ↗

Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging InterventionsSemantic proximity Read ↗

The Role of the Senescence-Associated Secretory Phenotype in Cardiovascular Disease Among the ElderlySemantic proximity Read ↗

Cellular Senescence and Ageing: Mechanisms and InterventionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.